Advertisement

Advertisement

Most Viewed Videos
Rowan T. Chlebowski, MD, PhD, on Diet and Breast Cancer: Trial Results
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
Pieter Tanis, MD, PhD, on Colon Cancer: Results From the COLOPEC Trial on Adjuvant HIPEC
Edward B. Garon, MD, on Non–Small Cell Lung Cancer: CheckMate 384 Trial on Nivolumab Dosing
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
Nicholas J. van As, MD, on Prostate Cancer: Results From the PACE-B Trial Comparing Radiotherapy Techniques
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Shoshana M. Rosenberg, ScD, on Quality of Life and the Impact of Breast Cancer Surgery
Heinz-Josef Lenz, MD, on Pancreatic Cancer Tumor Profiling and Treatment Response: Results From the COMPASS Trial
Eric Jonasch, MD, on Kidney Cancer: A Year in Review
Jedd D. Wolchok, MD, PhD, on The Future of Immunotherapy: Keynote Lecture
Silke Gillessen, MD, on Prostate Cancer: Results From the REDUSE Trial on Denosumab
Stefanie C. Fischer, MD, on Nonseminoma: Outcomes After Adjuvant Bleomycin/Etoposide/Cisplatin
Brian I. Rini, MD, on Renal Cell Cancer: Risk Stratification After Resection of Localized Disease

Advertisement

Advertisement



;
Advertisement